Open-label, Multicenter Study Assessing Preference for Deferasirox Film-coated Tablet Compared to Dispersible Tablet
Status:
Completed
Trial end date:
2021-03-11
Target enrollment:
Participant gender:
Summary
Study to evaluate patient preference of deferasirox film-coated tablet (FCT) or deferasirox
dispersible tablet (DT) in patient with transfusion - dependent thalassemia or
non-transfusion -dependent thalassemia as measured by preference questionnaire at Week 48